Filter
254
Featured
21
3
Language
Document type
115
44
37
22
11
11
4
4
3
2
1
Countries / Regions
11
5
5
4
4
3
3
2
2
2
2
2
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
27
14
3
1
PATA is an action network of health providers and health facilities in sub-Saharan Africa. Our goal is to effect positive change in paediatric and adolescent HIV policy and service delivery on the frontline.
The PATA network offers a powerful platform for regional collaboration, capacity building
...
Pregnancy often results in exclusion from clinical trials of antiretroviral (ARV) drugs, resulting in limited data on pharmacokinetics (PK), drug safety, and the efficacy of new ARV drugs in pregnancy and lactation. However, pregnancy, lactation, or the potential for pregnancy should not preclude th
...
The federally approved clinical practice guidelines for HIV/AIDS are developed by panels of experts in HIV care. More information about the panels can be found in each set of guidelines.
The recommendations in these guidelines represent the current, evidence-based consensus of the U.S. Departmen
...
Men lag behind women regarding use of HIV services and represent the majority of individuals living with uncontrolled HIV, advanced HIV, and who experience HIV-related mortality. Men (15+) globally are less likely than women (15+) to know their HIV status (83% for men vs 91% for women), be on antire
...
A historic funding crisis is threatening to unravel decades of progress unless countries can make radical shifts to HIV programming and funding. The report highlights the impact that the sudden, large-scale funding cuts from international donors are having on countries most affected by HIV. Yet it a
...
This publication provides guidance for planning country-specific programming to achieve the triple elimination of mother-to-child (or vertical) transmission of HIV, syphilis and hepatitis B virus. It is based on the WHO Triple Elimination Framework, which promotes an integrated, person-centred appro
...
The findings of the report are both urgent and devastating. At the current rate of progress, by 2040 we would still have 1.9 million new HIV infections and 990,000 AIDS-related deaths in children. But if funding for HIV prevention and treatment continues to fall as current trends suggest, the world
...
WHO updated recommendations on HIV clinical management: recommendations for a public health approach
recommended
This document provides an overview of the updated World Health Organization recommendations for HIV clinical management, which focus on optimizing antiretroviral therapy, preventing vertical transmission, and enhancing tuberculosis prevention among individuals with HIV. These updates are intended to
...
The information in the brief version is excerpted directly from the full-text guidelines. The brief version is a compilation of the tables and boxed recommendations. The guidelines were updated to comply with Executive Orders
Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents With HIV
recommended
The Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and
Adolescents With HIV document is published in an electronic format and updated as relevant changes
in prevention and treatment recommendations occur.
Guidelines for the Prevention and Treatment of Opportunistic Infections in Children With and Exposed to HIV
recommended
Full Guidelines
Dosing Recommendations for Prevention and Treatment
Although strides have been made in the HIV response, children are still affected by the epidemic
Progress in reducing new HIV infections among children has stagnated in recent years
About nine per cent of all orphans globally have lost one or both parents due to an AIDS-related cause
In order to ramp up our efforts in the fight against AIDS, there is a need for more concentrated focus on adolescents and young people
About six in ten adolescents 10-19 years of age living with HIV are on antiretroviral medications
Slightly more than half of children under 15 years of age living with HIV are on antiretroviral medications
The Lancet HIV Volume 12, Issue 6e459-e462June 2025
